Klotho Neurosciences, Inc.
KLTO
Revenue
0.00
0.000.00%
-Assets
3.31M
▼-16.28M▼-83.10%
3 Months ChangeLiabilities
4.86M
▼-3.63M▼-42.78%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001213900-24-092913
2024-10-31
Form 8-K
ID: 0001213900-24-092389
2024-10-21
Form 8-K
ID: 0001213900-24-089335
2024-10-02
Form 8-K
ID: 0001213900-24-084456
2024-08-30
Form 8-K
ID: 0001213900-24-074551
2024-08-22
Form 8-K
ID: 0001213900-24-071578
2024-08-22
Form 8-K
ID: 0001213900-24-071576
2024-08-19
Form 10-Q
ID: 0001213900-24-070786
2024-08-05
Form 8-K
ID: 0001213900-24-065203
2024-06-27
Form 8-K
ID: 0001213900-24-056719